Noevir Holdings Co., Ltd. (TYO:4928)

Japan flag Japan · Delayed Price · Currency is JPY
4,625.00
+25.00 (0.54%)
At close: Mar 9, 2026
9.60%
Market Cap 157.97B
Revenue (ttm) 63.39B
Net Income (ttm) 8.38B
Shares Out 34.16M
EPS (ttm) 245.28
PE Ratio 18.86
Forward PE 19.48
Dividend 230.00 (5.00%)
Ex-Dividend Date Sep 29, 2025
Volume 114,400
Average Volume 69,740
Open 4,550.00
Previous Close 4,600.00
Day's Range 4,510.00 - 4,650.00
52-Week Range 3,885.00 - 4,795.00
Beta 0.12
RSI 47.83
Earnings Date May 13, 2026

About Noevir Holdings

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and... [Read more]

Founded 1964
Employees 1,354
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4928
Full Company Profile

Financial Performance

In fiscal year 2025, Noevir Holdings's revenue was 64.72 billion, an increase of 1.41% compared to the previous year's 63.82 billion. Earnings were 8.03 billion, an increase of 0.75%.

Financial Statements

News

There is no news available yet.